Cambridge Investment Research Advisors’s Stem STEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,202
Closed -$8K 3754
2025
Q1
$8K Buy
1,202
+58
+5% +$672 ﹤0.01% 3486
2024
Q4
$14K Sell
1,144
-254
-18% -$2.19K ﹤0.01% 3438
2024
Q3
$10K Buy
1,398
+189
+16% +$2.97K ﹤0.01% 3391
2024
Q2
$27K Sell
1,209
-133
-10% -$3.9K ﹤0.01% 3253
2024
Q1
$59K Sell
1,342
-309
-19% -$17.2K ﹤0.01% 3202
2023
Q4
$128K Sell
1,651
-382
-19% -$26.3K ﹤0.01% 2999
2023
Q3
$172K Sell
2,033
-442
-18% -$50.5K ﹤0.01% 2867
2023
Q2
$283K Sell
2,475
-618
-20% -$61.3K ﹤0.01% 2577
2023
Q1
$351K Buy
3,093
+179
+6% +$30.3K ﹤0.01% 2348
2022
Q4
$521K Sell
2,914
-72
-2% -$17.3K ﹤0.01% 1981
2022
Q3
$797K Buy
2,986
+633
+27% +$162K ﹤0.01% 1629
2022
Q2
$337K Buy
2,353
+306
+15% +$50.9K ﹤0.01% 2279
2022
Q1
$451K Buy
2,047
+174
+9% +$40.5K ﹤0.01% 2196
2021
Q4
$711K Sell
1,873
-231
-11% -$100K ﹤0.01% 1822
2021
Q3
$1M Buy
2,104
+559
+36% +$294K 0.01% 1515
2021
Q2
$1.11M Buy
1,545
+291
+23% +$158K 0.01% 1462
2021
Q1
$667K Buy
+1,254
New +$805K ﹤0.01% 1690

Other funds holding STEM

Cambridge Investment Research Advisors's STEM Position: Q2 2025 in Review

Cambridge Investment Research Advisors sold out of Stem (STEM) in Q2 2025, closing a stake of 1,202 shares — an estimated $8K sold.

Cambridge Investment Research Advisors first reported a position in STEM in Q1 2021 and held it in 17 quarters. The position peaked at $1.11M in Q2 2021. 81 funds tracked by Wall St. Rank hold STEM as of Q2 2025.

  • Cambridge Investment Research Advisors reported no remaining Stem position as of Q2 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,202 Stem shares in Q2 2025, an estimated $8K.
  • Cambridge Investment Research Advisors first reported a position in Stem in Q1 2021 and held it in 17 quarters.
  • Cambridge Investment Research Advisors's Stem position peaked at $1.11M in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Stem as of Q2 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.